{'fraction_non_alphanumeric': 0.02310536044362292, 'fraction_numerical': 0.0036968576709796672, 'mean_word_length': 5.9423076923076925, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The frequency of musculoskeletal manifestations among psoriatic patients

Background: psoriasis (Pso) is a prototype of Th1 proinflammatory cytokines mediated by an immunological dysfunction. It is usually seen as inflammatory skin disease with far-reaching systemic consequences of uncertain aetiology. There is increasing evidence of the seriousness of psoriatic skin disease as a significant danger of developing outbreaks of extracutaneous diseases and of the greater frequency of co-morbid illness linked with cardiometabolic dysfunction and Psoriatic Arthritis (PsA). Methods: 200 psoriatic patients were included in this research. Patients were split into two groups depending on whether there was bursitis or not. Patients were tested and examined in history. Results: Bursitis patients had a higher rate of psoriatic arthritis, enthesitis, heel condition, cardiovascular illness, serum higher uric acid, longer duration of psoriasis disease than bursitis-free group. Conclusions: Longer duration of psoriasis, leading to greater cardiovascular and musculoskeletal symptoms.